The Big Pharma is paying up to $1.5 billion, split between an upfront fee and a milestone payment, to buy shingles vaccine ...

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services ...

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people have received at least one mRNA vaccine, and research ...

A $140 million fund has been launched by Coefficient Giving, a health-focused philanthropic organisation, to fund R&D into ...

The MV Hondius outbreak has renewed focus on hantavirus vaccines, with Moderna developing an mRNA-based shot. The Andes strain's high mortality rate underscores the urgency for effective solutions.

A small number of experimental vaccines and therapies are being assessed, while global health authorities are also reviewing ...

WASHINGTON, D.C. – The GOP-led House Judiciary Committee is investigating Pfizer's COVID-19 vaccine development timeline. They are focusing on allegations that vaccine testing results were delayed ...